These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35803132)

  • 1. Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis.
    Setyo Budi D; Fahmi Rofananda I; Reza Pratama N; Sutanto H; Sukma Hariftyani A; Ratna Desita S; Zinedinita Rahmasari A; Pudy Asmarawati T; Agung Waskito L; Dyah Kencono Wungu C
    Int Immunopharmacol; 2022 Sep; 110():109014. PubMed ID: 35803132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ozone adjuvant therapy in COVID-19 patients: A meta-analysis study.
    Jafari-Oori M; Vahedian-Azimi A; Ghorbanzadeh K; Sepahvand E; Dehi M; Ebadi A; Izadi M
    Front Med (Lausanne); 2022; 9():1037749. PubMed ID: 36438064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
    Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
    J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
    Srivastava A; Rengaraju M; Srivastava S; Narayan V; Gupta V; Upadhayay R
    Trials; 2021 Feb; 22(1):130. PubMed ID: 33573696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.
    Toews I; George AT; Peter JV; Kirubakaran R; Fontes LES; Ezekiel JPB; Meerpohl JJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD008687. PubMed ID: 29862492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of dexmedetomidine versus propofol on extubation times, length of stay and mortality rates in adult cardiac surgery patients: a systematic review and meta-analysis.
    Nguyen J; Nacpil N
    JBI Database System Rev Implement Rep; 2018 May; 16(5):1220-1239. PubMed ID: 29762314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; do Nascimento-Júnior EM; Barreto-Alves JA; Fakhouri R; Ferreira LC
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1813-1821. PubMed ID: 36066651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Frei A; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010257. PubMed ID: 30371937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-pharmacological interventions for sleep promotion in the intensive care unit.
    Hu RF; Jiang XY; Chen J; Zeng Z; Chen XY; Li Y; Huining X; Evans DJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008808. PubMed ID: 26439374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.